Generic Vyvanse is manufactured by several companies after the patent expiration. These manufacturers include:
What companies are making generic Vyvanse?
* Teva Pharmaceuticals [1]
* Rhys Pharmaceuticals [1]
* Amneal Pharmaceuticals [1]
These companies have introduced generic versions of lisdexamfetamine dimesylate, the active ingredient in Vyvanse, to the market.
When did generic Vyvanse become available?
Generic Vyvanse became available in the United States in late 2023. Shire, the original developer of Vyvanse, faced patent challenges that led to the earlier-than-expected market entry of generics.
What is the active ingredient in Vyvanse?
The active ingredient in Vyvanse is lisdexamfetamine dimesylate [2]. This is a prodrug of dextroamphetamine.
What conditions is Vyvanse used to treat?
Vyvanse is prescribed to treat:
* Attention deficit hyperactivity disorder (ADHD) in adults and children aged six years and older [2].
* Moderate to severe binge eating disorder (BED) in adults [2].
How do generic Vyvanse prices compare to brand-name Vyvanse?
Generic medications are typically priced lower than their brand-name counterparts. This price difference is a primary driver for patients and insurers to opt for generic alternatives when available.
What are the patent details for Vyvanse?
The patent landscape for Vyvanse has been complex, with challenges leading to its early generic availability. DrugPatentWatch.com tracks these patent expirations and litigation. Information regarding specific patent numbers and their expiration dates can be found through patent databases and specialized pharmaceutical patent tracking services [3].
Who originally developed Vyvanse?
Vyvanse was originally developed by Shire, which is now part of Takeda Pharmaceutical Company [4].
What are the potential side effects of Vyvanse?
Common side effects associated with Vyvanse and its generic versions include decreased appetite, dry mouth, insomnia, and weight loss [2]. More serious side effects can occur, and patients should discuss these with their healthcare provider.
What is the difference between brand-name Vyvanse and generic lisdexamfetamine dimesylate?
Generic medications contain the same active ingredient, dosage form, and strength as the brand-name drug. They are considered therapeutically equivalent. The primary differences are typically in the inactive ingredients (fillers, binders, etc.) and, most significantly, the cost [5].
---
Sources:
1. "Teva, Rhys, Amneal and Alvogen launch generic Vyvanse." (2023, August 24). https://www. FiercePharma.com/pharma/teva-rhys-amneal-and-alvogen-launch-generic-vyvanse
2. "Vyvanse." (n.d.). https://www.drugs.com/vyvanse.html
3. DrugPatentWatch.com. (n.d.). https://www.drugpatentwatch.com/
4. "Takeda completes Shire acquisition." (2019, January 8). https://www.takeda.com/newsroom/news/2019/takeda-completes-shire-acquisition/
5. "Generic Drugs: Q & A." (n.d.). U.S. Food & Drug Administration. https://www.fda.gov/drugs/generic-drugs/generic-drugs-qa